Literature DB >> 23669285

Tuberculous sepsis during antiviral HCV triple therapy.

Stephanie Hametner, Fabio Monticelli, Jan Marco Kern, Rainer Schöfl, Alexander Ziachehabi, Andreas Maieron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23669285     DOI： 10.1016/j.jhep.2013.05.005

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis.

Authors:  T Tieghi; R Marocco; V Belvisi; C Del Borgo; S Savinelli; M Lichtner; C M Mastroianni
Journal:  Infection       Date:  2013-10-22       Impact factor: 3.553

2.  Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes.

Authors:  Walter Spindelboeck; Angela Horvath; Monika Tawdrous; Bianca Schmerböck; Gabriele Zettel; Andreas Posch; Andrea Streit; Petra Jurse; Sandra Lemesch; Martin Horn; Gerit Wuensch; Philipp Stiegler; Rudolf E Stauber; Bettina Leber; Vanessa Stadlbauer
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

3.  High incidence of tuberculosis in patients treated for hepatitis C chronic infection.

Authors:  Silvia Naomi de Oliveira Uehara; Christini Takemi Emori; Renata Mello Perez; Maria Cassia Jacintho Mendes-Correa; Adalgisa de Souza Paiva Ferreira; Ana Cristina de Castro Amaral Feldner; Antonio Eduardo Benedito Silva; Roberto José Carvalho Filho; Ivonete Sandra de Souza E Silva; Maria Lucia Cardoso Gomes Ferraz
Journal:  Braz J Infect Dis       Date:  2016-02-09       Impact factor: 3.257
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.